Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Poestlberger, S; Menzel, C; Jakesz, R; Kubista, E; Marth, C; Greil, R.
ADDITION OF ZOLEDRONIC ACID (ZOL) TO ADJUVANT ENDOCRINE THERAPY IMPROVES DISEASE-FREE (DFS) AND RECURRENCE-FREE SURVIVAL (RFS) IN PREMENOPAUSAL WOMEN WITH HORMONE-RESPONSIVE EARLY BREAST CANCER (HREBC): MULTIVARIATE ANALYSES OF THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP 12 (ABCSG-12) TRIAL
ANN ONCOL. 2009; 20: 30-30.-IMPAKT Breast Cancer Conference; MAY 7-9, 2009; Brussels, BELGIUM.
[Poster]
Web of Science